510(k) Report

510(k) · Cleared

Cleared

Medrelief SE Series, Models SE-50, SE-100, SE-200, SE-300

K030998510(k) TraditionalCleared Oct 10, 2003193-day reviewClass II21 CFR 890.5850

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Healthonics, Inc. · IPF Stimulator, Muscle, Powered

Cleared on Oct 10, 2003 as substantially equivalent to K980040 (Nisha Communication Industries, 1998) and 3 other predicates after a 193-day review. Its family tree reaches back 1 generation to 1992. 3 later devices descend from it.

Decided
Oct 10, 2003
Review
193 days
Class
Class II
Product code
IPF
Recalls
None
Predicates
4

Its longest line of descent runs back 1 generation to K923914 (1992). 4 ancestors in all. 3 later devices descend from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2001: 1 other ancestor1998: 1 other ancestor1994: 1 other ancestor2006: 1 descendant cleared2007: 2 descendants clearedK923914 · IF-II (TM), Model 7200 · Medical Devices, Inc. · 19921990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 3 other ancestors 1 generation forward: 1 descendant2 generations forward: 2 descendants K923914 · IF-II (TM), Model 7200 · Medical Devices, Inc. · 19920
  1. Root · 1 generation backK923914 IF-II (TM), Model 7200Medical Devices, Inc. · 1992
  2. This deviceK030998 Medrelief SE Series, Models SE-50, SE-100, SE-200, SE-300Healthonics, Inc. · 2003
  3. Descendant · cites it directly · 2 of its ownK060669 Medrelief ST Series, Models RT-50, ST-100, ST 150, ST-200, ST-300Healthonics, Inc. · 2006
  4. Descendant · 2 generations on · 0 of its ownK062616 Wellnesspro 2010Intelsource Group, Inc. · 2007
  5. Descendant · 2 generations on · 0 of its ownK062325 RS-4I Muscle Stimulator FamilyRs Medical · 2007

Most influential descendants

Showing 3 of 3 · See all
  • K060669Medrelief ST Series, Models RT-50, ST-100, ST 150, ST-200, ST-300Healthonics, Inc. · 2006 · cites it directly2descendants
  • K062616Wellnesspro 2010Intelsource Group, Inc. · 2007 · 2 generations on0descendants
  • K062325RS-4I Muscle Stimulator FamilyRs Medical · 2007 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K923914IF-II (TM), Model 7200Medical Devices, Inc.1992—
0 (this device)K030998Medrelief SE Series, Models SE-50, SE-100, SE-200, SE-300Healthonics, Inc.2003—
+1K060669Medrelief ST Series, Models RT-50, ST-100, ST 150, ST-200, ST-300Healthonics, Inc.2006—
+2K062616Wellnesspro 2010Intelsource Group, Inc.2007—
+2K062325RS-4I Muscle Stimulator FamilyRs Medical2007—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199410
199810
200110

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200610
200720
FIG. 1 — Lineage of K030998, 1992–2007Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in IPF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new IPF device

  1. #1 K241433 EVE Synergy (EVE-20M)score 19.6 · 25 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (4)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K980040Electronic Muscle Stimulator - Microstim J-1304D
Summary page 1
…Microstim J-l304D, made by Nisha Communications Industries, Light Industrial Area, Jodhpur 342003 India, which was cleare,d for marketing by the FDA on July 13, 1998 as K980040; (2) in interferential stimulation functions to the I F 4 Model 7200, made by Medical Devices, Inc., 833 Third Street Southwest,…
Nisha Communication Industries1998—
*K923914IF-II (TM), Model 7200
Summary page 1
…e I F 4 Model 7200, made by Medical Devices, Inc., 833 Third Street Southwest, St. Paul, MN 55112-3483, which was cleared for marketing by the FDA on November 6, 1992 as K923914; and, (3) in microcurrent TENS stimulation functions to the original MedRelief device, made by Healthonics, Inc., 903 Main Street…
Medical Devices, Inc.1992—
*K003507Medrelief
Summary page 1
…to the original MedRelief device, made by Healthonics, Inc., 903 Main Street South, New Ellenton, SC 29803, which was cleared for marketing by the FDA on Feb. 21,2001 as K003507, and to the Home Microcurrent HMC, also made by Medical Devices, Inc., which was cleared for marketing by the FDA on March 14, 19…
Healthonics, Inc.2001—
*K935132Home Microcurrent HMC
Summary page 1
…the FDA on Feb. 21,2001 as K003507, and to the Home Microcurrent HMC, also made by Medical Devices, Inc., which was cleared for marketing by the FDA on March 14, 1994 as K935132. 000062 B. DEVICE DESCRIPTION. The M…
Medical Devices, Inc.1994—

What descends from it? (3)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K060669Medrelief ST Series, Models RT-50, ST-100, ST 150, ST-200, ST-300Healthonics, Inc.20062

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • None of the 4 ancestors has a recall.
  • Of its descendants, K060669 (Healthonics, Inc., 2006) has gone furthest, with 2 descendants of its own.

How does its category compare?

All IPF devices

IPF Stimulator, Muscle, Powered: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · IPF

3in 2025

2007: 82008: 62009: 72010: 42011: 42012: 42013: 102014: 42015: 32016: 72017: 52018: 52019: 42020: 92021: 152022: 72023: 92024: 72025: 32026 (partial year): 3
2007high 15 (2021) · low 3 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · IPF

257in 2025

2007: 143 days median2008: 140 days median2009: 216 days median2010: 121 days median2011: 275 days median2012: 269 days median2013: 180 days median2014: 264 days median2015: 43 days median2016: 113 days median2017: 110 days median2018: 73 days median2019: 133 days median2020: 121 days median2021: 98 days median2022: 108 days median2023: 255 days median2024: 201 days median2025: 257 days median2026 (partial year): 206 days median
2007high 275 (2011) · low 43 (2015)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · IPF

1in 2023

2008: 12011: 12012: 32023: 1
2007high 3 (2012) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · IPF

8in 2025

2007: 112008: 2132009: 1502010: 142011: 252012: 162013: 62014: 192015: 112016: 82017: 22018: 32019: 102020: 132021: 32022: 42023: 82024: 52025: 8
2007high 213 (2008) · low 2 (2017)2025

MAUDE reports naming product code IPF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20078143011
200861401213
200972160150
20104121014
20114275125
20124269316
20131018006
20144264019
2015343011
2016711308
2017511002
201857303
20194133010
20209121013
2021159803
2022710804
2023925518
2024720105
2025325708
202632060—

What is it indicated for?

The MedRelief SE-50 and SE-100, and the MedRelief SE-200 and SE-300 in subthreshold and interferential modes, are intended for the following indications: Relief of chronic intractable pain. Adjunctive treatment of post-surgical or post-traumatic acute pain. The MedRelief SE-200 and SE-300 in muscle stimulation mode are intended for the following indications: Relaxation of muscle spasms. Prevention or retardation of disuse atrophy. Muscle re-education.…

Read the full statement (136 words)

The MedRelief SE-50 and SE-100, and the MedRelief SE-200 and SE-300 in subthreshold and interferential modes, are intended for the following indications:

Relief of chronic intractable pain.

Adjunctive treatment of post-surgical or post-traumatic acute pain.

The MedRelief SE-200 and SE-300 in muscle stimulation mode are intended for the following indications:

Relaxation of muscle spasms.

Prevention or retardation of disuse atrophy.

Muscle re-education.

Increasing local blood circulation.

Maintaining or increasing range of motion

Immediate post-surgical stimulation of calf muscles to prevent venous thrombosis (SE-300 only).

For the SE-200 and SE-300 in muscle stimulation mode, the lowest three intensity settings may not provide effective muscle contractions to achieve the indications for use, especially when applied to large muscles or muscle groups. These settings are provided so that the intensity may be ramped up slowly for improved user comfort.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K030998: Medrelief SE Series, Models SE-50, SE-100, SE-200, SE-300.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K030998

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026